(PharmaNewsWire.Com, November 29, 2017 ) Biopreservation Media is being increasingly used by the life sciences companies to develop tissue or cell related therapies. Many academic institutions, governments, healthcare establishments, pharmaceuticals and bio technology companies are funding biorepositories and bio banks clinical research. Increasing healthcare expenditure and rise in demand for novel bio-preservatives techniques is expected to aid the growth of the market.
Biopreservation is a process of storing the biological samples in an environment suitable for their survival. Biological samples that can be stored with the help of biopreservation typically include plasma, saliva, cells, tissues, body fluids and organs. Biobanks are increasingly adopting automated systems and software tools to improve storage, management and retrieval of HBS without sacrificing sample sustainability and integrity. Given the growing volume and diversity of Human Biological Samples that need to be preserved, efficient utilization of storage space down to each refrigerator or a freezer unit is critical. With the emergence of Micro Electromechanical Systems (MEMS) and Radio Frequency Identification Systems (RFIS) as a cost effective and error free technologies for labelling bio samples, biobanks has able to serve several long term benefits compared to the traditional methods.
The drivers of the biopreservation market include increasing healthcare expenditure, increased demand for preserving new-borns cord cells, increasing R&D spending on research advances in regenerative market, drug discovery and biobanks, investments by government and non-government corporate organizations. Advancements in the field of personalised and diagnostics medicines, increasing biopreservation applications and new facilities are also expected to act as a growth catalyst for the market. However, the market growth is hampered by a few restraints that include high cost related to technologically advanced products and stability issues of specimens.
Biopreservation Market is segmented based on type, bio-specimens, Application, end-user and Region
Based on Type
biopreservation media
biopreservation equipment
lab information system management
Based on bio-specimens
human tissue samples
organs
stem cells and others
Based on Application
therapeutic applications
research applications
clinical trials and others
Based on End User
biobanks
gene banks
hospitals and others
Based on Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
The major players in the biopreservation market include BioLife Solutions, Inc., Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, BioCision LLC, VWR Corporation, Cesca Therapeutics Inc., Taylor-Wharton, So-Low Environmental Equipment Co., Panasonic Corporation and Lifeline Scientific Inc.
About Market Data Forecast Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
